164 Comprehensive methods to assess pharmacokinetics and monitor for viral shedding, replication competence, and immunogenicity of BI 3720931 in the first-in-human Lenticlair 1 Phase I/II trial

Saved in:
Bibliographic Details
Published inJournal of cystic fibrosis Vol. 23; p. S91
Main Authors Matter, A., Zaslavskaia, L., Graca, K., Ye, S., Place, C., Coble, K., Franti, M., Huang, F., Seibold, W., Ashour, J.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2024
Online AccessGet full text

Cover

More Information
ISSN:1569-1993
DOI:10.1016/S1569-1993(24)01004-X